BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38448130)

  • 21. The challenge of cardiovascular risk assessment in Chronic Kidney Disease; is there a role for CTA and FFR
    Weir-McCall JR; Sarnak MJ; Nørgaard BL
    J Cardiovasc Comput Tomogr; 2022; 16(5):452-453. PubMed ID: 35717528
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial Flow Reserve and Coronary Calcification in Prognosis of Patients With Suspected Coronary Artery Disease.
    Aljizeeri A; Ahmed AI; Alfaris MA; Ahmed D; Farea J; Elneama A; Suliman I; Alharthi M; Ahmed A; Alsaileek A; Al-Mallah MH
    JACC Cardiovasc Imaging; 2021 Dec; 14(12):2443-2452. PubMed ID: 33744156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine Coronary Atherosclerosis Imaging in the Cardiovascular Risk Assessment of Prediabetes and Diabetes.
    Mendes TB; Bittencourt MS
    Circ Cardiovasc Imaging; 2023 Oct; 16(10):e016079. PubMed ID: 37772410
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac Positron Emission Tomography-Magnetic Resonance Imaging: Current Status and Future Directions.
    Lau JMC; Raptis DA; Laforest R; Nensa F; Zheng J; Gropler RJ; Woodard PK
    J Thorac Imaging; 2018 May; 33(3):139-146. PubMed ID: 29489584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging.
    Farhad H; Dunet V; Bachelard K; Allenbach G; Kaufmann PA; Prior JO
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1203-10. PubMed ID: 23660750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortic stiffness effectively risk stratifies diabetic patients with suspected myocardial ischemia undergoing vasodilatory stress perfusion cardiac magnetic resonance.
    Pengyos S; Boonyasirinant T; Kaolawanich Y
    BMC Cardiovasc Disord; 2023 Oct; 23(1):502. PubMed ID: 37817068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.
    Murthy VL; Naya M; Foster CR; Hainer J; Gaber M; Dorbala S; Charytan DM; Blankstein R; Di Carli MF
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1025-34. PubMed ID: 23058070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.
    Potier L; Chequer R; Roussel R; Mohammedi K; Sismail S; Hartemann A; Amouyal C; Marre M; Le Guludec D; Hyafil F
    Cardiovasc Diabetol; 2018 Jan; 17(1):11. PubMed ID: 29325551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior SARS-CoV-2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography.
    Weber B; Parks S; Huck DM; Kim A; Bay C; Brown JM; Divakaran S; Hainer J; Bibbo C; Taqueti V; Dorbala S; Blankstein R; Woolley AE; Di Carli MF
    J Am Heart Assoc; 2022 Oct; 11(20):e025844. PubMed ID: 36250654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pet Imaging and its Application in Cardiovascular Diseases.
    Li Z; Gupte AA; Zhang A; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2017; 13(1):29-33. PubMed ID: 28413580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron-Emission Tomography Quantitative Measurements of Myocardial Blood Flow: Just the Facts….
    Gewirtz H; Iskandrian AE; Morgan C; Schelbert HR
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1864-1867. PubMed ID: 31488254
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac
    Shrestha UM; Sciammarella M; Pampaloni MH; Botvinick EH; Gullberg GT; DeMarco T; Seo Y
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1461-1472. PubMed ID: 33123937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Myocardial Perfusion Imaging Diagnostics Improve Detection of Functionally Significant Coronary Artery Stenosis by 13N-ammonia Positron Emission Tomography.
    Lee JM; Kim CH; Koo BK; Hwang D; Park J; Zhang J; Tong Y; Jeon KH; Bang JI; Suh M; Paeng JC; Cheon GJ; Na SH; Ahn JM; Park SJ; Kim HS
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram.
    Petretta M; Acampa W; Evangelista L; Daniele S; Zampella E; Assante R; Nappi C; Cantoni V; Fiumara G; Cuocolo A
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):588-93. PubMed ID: 24472632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography myocardial perfusion vs
    Williams MC; Mirsadraee S; Dweck MR; Weir NW; Fletcher A; Lucatelli C; MacGillivray T; Golay SK; Cruden NL; Henriksen PA; Uren N; McKillop G; Lima JA; Reid JH; van Beek EJ; Patel D; Newby DE
    Eur Radiol; 2017 Mar; 27(3):1114-1124. PubMed ID: 27334015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: a critical review.
    Yerramasu A; Maggae SV; Lahiri A; Anand DV
    J Nucl Cardiol; 2008; 15(1):13-22. PubMed ID: 18242475
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular imaging to guide primary prevention.
    Meah MN; Dweck MR; Newby DE
    Heart; 2020 Aug; 106(16):1267-1275. PubMed ID: 32451365
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study.
    Ng MY; Zhou W; Vardhanabhuti V; Lee CH; Yu EYT; Wan EYF; Chan K; Yan AT; Ip TP; Yiu KH; Wintersperger BJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):42. PubMed ID: 32234045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial blood flows and reserves on solid state camera: Correlations with coronary history and cardiovascular risk factors.
    Ferenczi P; Couffinhal T; Mamou A; Mamou Y; Ceyrat Q; Bordenave L; Coste P; Pinaquy JB
    J Nucl Cardiol; 2022 Aug; 29(4):1671-1678. PubMed ID: 34036528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity?
    Dixon DL; Carbone S
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3316. PubMed ID: 32223033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.